Cancer News Network

Cancer Awareness , Developments in Cancer Research and News on Cancer

Monday, October 02, 2006

Eating fatty fish can reduce the risk of cancer

Swedish researchers have found that eating fatty fish, which is rich in vitamin D and omega 3 fatty acids, can reduce the risk of kidney cancer significantly. Fish like salmon, herring, sardines and mackerel were defined as fatty fish by researchers, while tuna and cod were considered to be lean fish.

A study carried out by ‘Journal of the American Medical Association’ revealed that women eating fatty fish once a week at a lesser risk to cancer compared to others, whereas, eating three fish a month for a period of 10years would reduce cancer risk by nearly 74 percent.

Kidney cancer also referred to as renal cell carcinoma is one of the most common forms of cancer in the United States with a very low survival rate. It is the most common form of cancer in women above 40yrs of age.

Labels: , , , ,

3 Comments:

Anonymous buy drugs without prescription said...

Fatty fish, in the Wolk study, included salmon, herring, sardines, and mackerel. It doesn't prove fatty fish prevents cancer. But eating fatty fish once or twice a week is good for you. Please check out site. to get buy Veenat 100mg tablets online from Online medicine store.dicuss with a doctor before taking the medicine .

10:39 PM  
Anonymous Buy Medications Online said...

Fatty fish, included salmon, herring, sardines, and mackerel. It doesn't prove fatty fish prevents cancer. But eating fatty fish once or twice a week is good for you. buy Veenat 100mg tablets online from Online medicine store.

11:29 PM  
Anonymous buy xtane online said...

There are several leading cancer centers around the world, many of which are in the United States. Xtane 25mg Tablet is used to treat early breast cancer in women who have experienced menopause and who have already been treated with a medication called tamoxifen for 2 to 3 years. IT works by reducing the amount of estrogen made in the body. These are known as estrogen receptor-positive or ER+ breast cancers.

11:07 PM  

Post a Comment

<< Home